MRP 80.25/-STRIP

Composition

Each uncoated bilayered tablet contains: Glimepiride IP 1 mg + Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg + Metformin Hydrochloride IP 500 mg (In Extended Release Form) + Excipients q.s. (DOUBLE COLOR)

Doses

As Directed by Physician

Description

Glimepiride + Metformin + Pioglitazone is a combination of three antidiabetic medicines: Glimepiride , Metformin and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Pioglitazone is a thiazolidinedione which further increases insulin sensitivity.